|
Issue 1,546: January
27, 2021
|
 |
 |
|
|
| Top Stories |
|
Featured Resources
Journal Articles and Newsletters
On the Lighter Side
Top Stories
Watch virtual ACIP meetings on
January 27 and February 24–25; no registration is required
Live, virtual meetings of the Advisory Committee on Immunization Practices (ACIP) will be held on January 27 and February 24–25.
The respective agendas (including times) are posted before the meetings and are expected to feature COVID-19 vaccination. No registration is
required to watch the live ACIP meeting or listen via telephone. Look for instructions on how to sign up for public comment at the Public Comment tab of
the ACIP web page.
Related Link
- ACIP
gateway page for recordings and content from previous meetings, as well as information about future meetings
Back to top
MMWR report on Moderna COVID-19 vaccine addressing allergic reactions
after first doses published December 21, 2020–January 10, 2021
CDC published Allergic Reactions including Anaphylaxis after Receipt of the First Dose of Moderna COVID-19 Vaccine—United States,
December 21, 2020–January 10, 2021 in the MMWR Early Release issued on January 22. Portions of
the summary are reprinted below.
During December 21, 2020–January 10, 2021, monitoring by the Vaccine Adverse Event Reporting System detected 10 cases of anaphylaxis
after administration of a reported 4,041,396 first doses of Moderna COVID-19 vaccine (2.5 cases per million doses administered). In nine cases, onset
occurred within 15 minutes of vaccination. No anaphylaxis-related deaths were reported.…
Locations administering COVID-19 vaccines should adhere to CDC guidance, including screening recipients for contraindications and precautions, having
necessary supplies and staff members available to manage anaphylaxis, implementing recommended postvaccination observation periods, and
immediately treating suspected anaphylaxis with intramuscular epinephrine injection.
Access the MMWR Early Release article in HTML format or in PDF format.
Related Links
Back to top
CDC updates clinical considerations for use of mRNA COVID-19 vaccines
CDC updated its Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United
States. With permission, a CDC partner message is summarized below.
Updated recommendations on intervals between the first and second dose
- Language added to clarify doses inadvertently administered earlier than the grace period should not be repeated
- Language added: “The second dose should be administered as close to the recommended interval as possible. However, if it is
not feasible to adhere to the recommended interval, the second dose of Pfizer-BioNTech and Moderna COVID-19 vaccines may be scheduled for
administration up to 6 weeks (42 days) after the first dose. There are currently limited data on efficacy of mRNA COVID-19 vaccines administered
beyond this window. If the second dose is administered beyond these intervals, there is no need to restart the series.”
Updated recommendations on interchangeability of vaccine products
- Language added to suggest strategies to help assure patients receive the second dose with the appropriate product and interval between
doses:
- Providing vaccination record cards, asking recipients to bring their card to their second-dose appointment, and encouraging
recipients to make a backup copy (e.g., photographing the card with their phone)
- Encouraging recipients to enroll in VaxText, a free text message-based platform, to receive COVID-19 vaccination
second-dose reminders; to enroll, text ENROLL to 1-833-VaxText (829-8398)
- Recording each vaccination in the immunization information system (IIS)
- Recording vaccination in the patient’s medical record
- Making an appointment for the second dose before the recipient leaves, to increase the likelihood that patients will return to the
same vaccination site
Updated language on vaccination of persons with a history of SARS-CoV-2 infection
- “Data from clinical trials indicate that mRNA COVID-19 vaccines can safely be given to persons with evidence of a prior SARS-CoV-2
infection”
- “Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess for prior infection for the purposes of vaccine
decision-making is not recommended”
- “While there is no recommended minimum interval between infection and vaccination, current evidence suggests that the risk of SARS-CoV-2 reinfection is low in the months after initial infection but may increase with
time due to waning immunity. Thus, while vaccine supply remains limited, persons with recent documented acute SARS-CoV-2 infection may
choose to temporarily delay vaccination, if desired, recognizing that the risk of reinfection, and therefore the need for vaccination, may increase with time
following initial infection.”
New vaccination recommendations with a history of dermal fillers
- Language added: “Infrequently, persons who have received dermal fillers may develop swelling at or near the site of filler injection
(usually face or lips) following administration of a dose of an mRNA COVID-19 vaccine. This appears to be temporary and can resolve with medical
treatment, including corticosteroid therapy. mRNA COVID-19 vaccines may be administered to persons who have received injectable dermal fillers
who have no contraindications to vaccination. No additional precautions are needed. However, these persons should be advised to contact their
healthcare provider for evaluation if they develop swelling at or near the site of dermal filler following vaccination.”
Additional resources on vaccine excipients (Appendix B)
- Language added in Appendix B: “As of January 21, 2021, mRNA COVID-19 vaccines are the only currently available vaccines in the
United States that contain PEG, though several vaccines contain polysorbate (more information can be found in CDC’s vaccine excipient summary)”
CDC is expected to update other documents soon, including standing orders, the prevaccination screening form, and vaccine administration
guidance.
View CDC's Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United
States.
Back to top
CDC publishes media statement from its new director, Dr. Rochelle
Walensky
On January 20, U.S. President Joe Biden named Rochelle P. Walensky, MD, MPH, as director of CDC. A portion of Dr. Walensky's statement is reprinted below.
...I am proud to join this agency, and I recognize the seriousness of the moment. The toll that the COVID-19 pandemic has had on America is truly
heartbreaking — for the loss of our loved ones and our beloved ways of life. At Massachusetts General Hospital, I saw firsthand the many difficulties
this pandemic brings to our frontline workers and first responders, hospitals and public health systems, communities, and loved ones.
Better, healthier days lie ahead. But to get there, COVID-19 testing, surveillance, and vaccination must accelerate rapidly....
America and the world are counting on CDC’s science and leadership. Just as it has since the beginning of the pandemic, CDC will continue to
focus on what is known — and what more can be learned — about the virus to guide America. As part of that promise, CDC’s
Principal Deputy Director Anne Schuchat will begin leading a comprehensive review of all existing guidance related to COVID-19. Wherever needed, this
guidance will be updated so that people can make decisions and take action based upon the best available evidence....
Related Links
Back to top
CDC launches two COVID-19 vaccination communication toolkits for community-
based organizations and essential workers
CDC has released two new toolkits with ready-to-use materials to help build confidence about COVID-19 vaccination. CDC’s COVID-19 Vaccine Communication Toolkit for Community-Based Organizations and COVID-19 Vaccine Communication Toolkit for Essential Workers include:
- Guides for building vaccine confidence within community-based organizations and critical infrastructure sectors
- Turn-key slide decks for virtual town halls or other informational meetings
- Posters and flyers for multiple occupations and settings
- Fact sheets and FAQs in eight languages
- Newsletter content and letters to members
- Social media sample messages
- Printable buttons/stickers for individuals to wear once they’ve gotten their vaccine
 
View CDC’s COVID-19 Vaccine Communication Toolkit for Community-Based
Organizations and COVID-19 Vaccine Communication Toolkit for Essential
Workers today!
Back to top
HHS releases a 5-year Vaccines National
Strategic Plan, focused on protection across the lifespan
On January 19, the U.S. Department of Human Health Services (HHS) released its Vaccines National Strategic Plan:
2021–2025 (PDF).
 
This vaccine plan sets forth a vision for how the United States will be a place where vaccine-preventable diseases are eliminated through safe and
effective vaccination across the lifespan.
The vaccine plan includes five goals to guide planning efforts:
- Foster innovation in vaccine development and related technologies
- Maintain the highest possible levels of vaccine safety
- Increase knowledge of and confidence in routinely recommended vaccines
- Increase access to and use of all routinely recommended vaccines
- Protect the health of the nation by supporting global immunization efforts
Related Links
Back to top
Vaccinate Your Family launches state legislation
tracker
Vaccinate Your Family has launched its state legislation tracker with information on new and existing vaccine-related
legislation. Updated each morning, the tracker has an interactive state map and contact information for state legislators to encourage their support of
immunizations.
Sign up for Immunization Alerts from Vaccinate Your Family to get more information about what’s happening
across the country and how you can help support vaccinations for people of all ages.
Related Links
Back to top
Learn about the work of this new organization, Science and Families Engaging
(SAFE) Communities Coalition and Action Fund
The Science and
Families Engaging (SAFE) Communities Coalition and Action Fund is a pair of organizations with a simple mandate:
- Advocate for pro-science legislation
- Elect pro-science candidates
- Counter anti-vaccination candidates
The SAFE Communities Coalition is an IRS section 527 political action committee that harnesses broad resources to counter the anti-vaccination
movement at every level of government, from local school boards to Congress, governors’ mansions, and more. The SAFE Action Fund is an IRS
501(c)(4) social-welfare organization that advocates for legislation and educates the public on pro-science messages.
To learn more about the SAFE Communities Coalition and Action Fund, visit safecommunitiescoalition.org or join their mailing list.
Back to top
"Vaccination Coverage with Selected Vaccines and Exemption Rates among
Children in Kindergarten—United States, 2019–20 School Year" published in MMWR
CDC published Vaccination Coverage with Selected Vaccines and Exemption Rates among Children in Kindergarten—United States,
2019–20 School Year in the January 22 issue of MMWR. A portion of a media summary of the
MMWR article appears below.
Before schools return to in-person learning, it’s important that districts and immunization programs increase efforts to follow-up with students
who are not fully vaccinated to maintain the high level of coverage necessary to protect children, families, and communities against vaccine-preventable
diseases....Overall, coverage was approximately 95% for the state-required number of vaccine doses that prevent diphtheria, tetanus, and acellular
pertussis (DTaP), measles, mumps, and rubella (MMR), and varicella. While 2.5% of kindergartners had an exemption from at least one vaccine, another
2.3% of kindergartners were not up to date for MMR and did not have a vaccine exemption. Considering the disruptions to healthcare provider operations
caused by the COVID-19 pandemic, extra effort will be required by healthcare providers, schools, and immunization programs to ensure all students are
caught up on vaccinations in preparation for a return to in-school learning.
Access the MMWR article in HTML format or in PDF format.
Related Link
- MMWR gateway page provides access to MMWR Weekly, MMWR Recommendations and
Reports, MMWR Surveillance Summaries, and MMWR Supplements
Back to top
IAC Spotlight! IAC offers a collection of its new COVID-19 vaccine resources for healthcare personnel
IAC has developed many new resources to help healthcare personnel stay up to date with COVID-19 vaccination information including:
Check back periodically as IAC's COVID-19 vaccine resources expand.
Back to top
Flu activity remains unusually low, but don't let
your guard down; make sure all of your patients get vaccinated against influenza
While seasonal
influenza activity in the U.S. remains lower than usual for this time of year, it is still important to make sure all of your patients age 6 months and
older are vaccinated. Flu vaccination can help save medical resources for the care of COVID-19 patients by reducing the burden of flu illness on
healthcare systems. If you don’t provide influenza vaccine at your site, please strongly recommend vaccination and refer to a site that does
vaccinate.
Boston Children’s Hospital, in partnership with CDC, has developed VaccineFinder, a user-friendly website to help adult and pediatric patients find flu and other
vaccines. Participating providers can now update supply estimates on VaccineFinder for a more accurate reporting. For questions or more information, contact
vaccine@healthmap.org.
Related Links
Back to top
IAC enrolls three new birthing institutions into its Hepatitis B Birth Dose Honor Roll;
four institutions qualify for additional years' honors
The Immunization Action Coalition (IAC) is pleased to announce that three new institutions have been accepted into its Hepatitis B Birth Dose Honor Roll, for a total of 528 honorees.
The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.
- St. Joseph’s Hospital North, Lutz, FL (92%)
- Ste. Genevieve County Memorial Hospital, Ste. Genevieve, MO (95%)
- St. Francis-Emory, Columbus, GA (94%)
One institution is being recognized for a second year:
- Bridgeport Hospital, Bridgeport, CT (92%)
Two institutions are being recognized for a fifth year:
- Franciscan Health Michigan City, Michigan City, IN (95%)
- Olivia Hospital & Clinic, Olivia, MN (92%)
One institution is being recognized for a sixth year:
- MetroHealth Medical Center, Cleveland, OH (96%)
The Honor Roll now includes 528 birthing institutions from 44 states, Puerto Rico, Guam, and an overseas U.S. military base. One hundred twenty-two
institutions have qualified for 2 years, 72 institutions have qualified three times, 37 institutions have qualified four times, 26 institutions have qualified five
times, 19 institutions have qualified six times, seven institutions have qualified seven times, two institutions have qualified eight times and one institution has
qualified nine times.
The Honor Roll is a key part of IAC’s major initiative urging the nation’s hospitals to Give Birth to the End of Hep B. Hospitals
and birthing centers are recognized for attaining high coverage rates for administering hepatitis B vaccine at birth and meeting specific additional criteria.
The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.
To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90 percent or greater, over a 12-
month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2)
implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection prior to hospital discharge.
Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IAC
Express’s approximately 52,000 readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants
from perinatal hepatitis B transmission.
Related IAC Resources
Back to top
IAC experts called on by news
media
With vaccines in the news so much lately, journalists have sought out IAC experts to communicate the intricacies of running a quality vaccination
program. Our insights have helped explain vaccines to the public and policy makers. We want to help them understand the complex work vaccinators do.
We've reached mass markets and local stations across the U.S. and overseas via print, radio, television, blogs, and more. Here is a
selection of our recent citations:
Related Link
Back to top
Not-to-miss immunization articles in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Back to top
Featured Resources
Help CDC test its new interactive Q&A web tool, the Flu ChatBot
CDC is pilot testing an interactive web feature called the CDC SmartFind Flu
ChatBot that answers common questions about flu and flu vaccines. A chatbot is a computer program designed to simulate conversation with
human users. CDC encourages website visitors to try it out. The
Flu Chatbot allows users to provide
feedback on its answers, which helps improve this resource.
Check out the
Flu ChatBot today!
Back to top
In IAC’s “Video of the Week,”
America's teens recruit Elvis in the fight against polio
In this January
2021 video, Cambridge University historian Stephen Mawdsley describes how teenagers, who comprised a third of new cases of polio in 1957,
devised strategies to appeal to their peers to increase polio vaccination. One strategy was to have Elvis Presley get vaccinated on television. This
successful fight against vaccine complacency, Mawdsley suggests, could provide important lessons for today.
Visit the whole collection at the
VOTW archive.
Back to top
Use IAC’s expanded “Repository of
Resources for Maintaining Immunization during the COVID-19 Pandemic” to catch up on routine immunization
IAC now offers more than 282 items in its Repository of Resources for Maintaining Immunization during the COVID-19
Pandemic gateway page. Located on the website of the National Network of Immunization Coalitions, a project of IAC, this repository includes links to
both national and state-level policies and guidance; advocacy materials, including talking points, webinars, press releases, articles, and social media posts;
and telehealth resources.
These resources are intended for healthcare settings, state and local health departments, professional societies, immunization coalitions, advocacy
groups, and the community. The resources can be sorted and searched by date, title, geographic area, source, type, age category, or setting.
If you have a resource to suggest for the repository, please send a message to info@immunizationcoalitions.org.
Related Link
Back to top
Great for workplace recognitions!
IAC’s elegantly designed “Vaccines Save Lives” black enamel pins show how much you value vaccination.
Several thousand sold already! IAC’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about
immunization. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also
provided.
Wear these
pins on clothing, uniforms, and white coats to show that you value vaccines! They make a meaningful gift for people who care about
immunization.
 
Click here for
"Vaccines Save Lives" pin pricing and ordering information.
Back to top
Valuable resources added to IAC's website
Mass-Vaccination-Resources.org to help set up mass vaccination clinics
The Immunization Action Coalition’s newest website, www.Mass-Vaccination-Resources.org, assists you in finding a wide range of ideas for
developing your own mass vaccination clinics. Mass vaccination efforts will be useful for expediting flu vaccination this fall and may be needed after
COVID-19 vaccines are licensed for use in large groups of people.
The website features a searchable list of resources for a variety of venues, including curbside, drive-through, and walk-through clinics; mobile medical
vans; pharmacies; and schools. The database contains guidance documents, toolkits, publications, and other helpful resources that can be adapted to
your community or individual healthcare setting.
Many of the documents were written in the pre-pandemic era and will need modification to ensure that additional protections, such as social distancing and
personal protective equipment, help safeguard against COVID-19 transmission.
More resources have been added, including:
In addition, IAC's archived, full-length webinar highlighting best practices and offering practical information for conducting a successful mass
vaccination clinic, Mass Vaccination Clinics: Challenges and Best Practices, can also be viewed on www.Mass-Vaccination-
Resources.org.
If you have a resource to suggest for the website, please send a message to info@mass-vaccination-resources.org.
The webinar and the new website are supported by a medical education grant from Seqirus.
Related Links
Back to top
Journal Articles and Newsletters
CHOP's Vaccine Education Center publishes January issue of Vaccine Update newsletter
The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia (CHOP) publishes a
monthly immunization-focused newsletter titled Vaccine Update. The
January issue includes the following articles:
Additional resources, including information booklets for patients, are available in the full
newsletter.
Access the sign-up form to subscribe to Vaccine Update.
Back to top
"Fake News and Science Denier Attacks on
Vaccines. What Can You Do?" published in Canada Communicable Disease Report
In the November 5 issue, Canada Communicable Disease Report published Fake News and Science Denier
Attacks on Vaccines. What Can You Do? The abstract is reprinted below.
Misinformation and disinformation ("fake news") about vaccines are contagious—travelling faster and farther than truth. The
consequences are serious; leading to negative impacts on health decisions, including vaccine acceptance, and on trust in immunization advice from public
health and/or healthcare professionals. This article provides a brief overview of evidence-based strategies to address vaccine deniers in public, in clinical
practice and in social situations. As well, a strategy to help differentiate between vaccine deniers and simple vaccine refusers in a practice or clinic is
provided. Five tactics are widely used by vaccine deniers: conspiracy; fake experts; selectivity; impossible expectations; and misrepresentation and false
logic. Recognizing and understanding these tactics can help protect against misinformation and science denialism propaganda. Highlighting the strong
medical science consensus on the safety and effectiveness of vaccines also helps. Carefully and wisely choosing what to say and speaking
up—whether you are at a dinner party, out with friends or in your medical office or clinic—is crucial. Not speaking up implies you agree with
the misinformation. Having healthcare providers recognize and address misinformation using evidence-based strategies is of growing importance as the
arrival of the coronavirus disease 2019 (COVID-19) vaccines is expected to further ramp up the vaccine misinformation and disinformation
rhetoric. Healthcare providers must prepare themselves and act now to combat the vaccine misinformation tsunami.
Back to top
On the Lighter Side
In 1999 PSA La Vacuna Es Protección from the U.S. Department of Health and Human Services, a narrator
describes how vaccines protect young children
In this 1999 public service announcement (PSA) titled La Vacuna Es Protección from the U.S. Department of Health and Human Services, the
narrator describes that vaccines are protection for young children. This PSA is part of a collection curated by vaccine expert William L. Atkinson, MD,
MPH.
Previous PSAs featured in “On the Lighter Side” are available when viewing this Vimeo video.
Back to top
|
